Adachi, Y; Miura, NN; Ohno, N; Tamura, H; Tanaka, S and Yadomae, T (1998). Enzyme immunoassay system for estimating the ultrastructure of (1,6)-branched (1,3)- beta-glucans. Carbohydr. Polym., 39: 225-229.
Al Tuwaijri, AS; Mahmoud, AA; Al Mofleh, IA and Al Khuwaitir, SA (1987). Effect of glucan on Leishmania major infection in BALB/c mice. J. Med. Microbiol., 23: 363-365.
Benacerraf, B and Sebastyen, MM (1957). Effect of bacterial endotoxins on the reticuloendothelial system. Fed. Proc., 16: 860-867.
Brown, GD and Gordon, S (2003). Fungal beta-glucans and mammalian immunity. Immunity, 19: 311-315.
Brown, GD; Herre, J; Williams, DL; Williament, JA; Marshall, ASJ and Gordon, S (2003). Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med., 197: 1119-1124.
Bohn, JA and BeMiller, JN (1995). Beta-(1,3)-D-glucan as biological response modifiers: A review of structure-function activity relationships. Carbohydr. Poly., 28: 3-14.
Carrow, D (1996). Beta-(1,3)-D-glucan as a primary immune activator. Townsend Lett. June. 86.
Cleary, JA; Kelly, GE and Husband, AJ (1999). The effect of molecular weight and beta-(1,6)- linkages on priming of macrophage function in mice by beta-(1,3)-D-glucan. Immunol. Cell Biol., 77: 395-403.
Di Luzio, NR; Williams, DL; McNamee, RB; Edwards, BF and Kitahama, A (1979). Comparative tumorinhibitory and anti-bacterial activity of soluble and particulate glucan. Int. J. Cancer, 24: 773-779.
Hoffman, OA; Olson, EJ and Limper, AH (1993). Fungal beta-glucans modulate macrophage release of tumor necrosis factor-alpha in response to bacterial liposaccharide. Immunol. Let., 37: 19-25.
Khosravi, AR; Franco, M; Shokri, H and Yahyaraeyat, R (2007). Evaluation of the effects of Zataria multiflora, Geranium pellargonium roseum, Myrth and Lemon peel essences on immune system function in experimental animals. J. Vet. Res., 62:119-123.
Kubala, L; Ruzickova, J; Nikova, K; Sandula, J; Ciz, M and Lojek, A (2003). The effect of beta-(1,3)-Dglucans, carboxymethylglucan and schizophyllan on human leukocytes in vitro. Carbohydr. Res., 338: 2835-2840.
Lee, JN; Lee, DY; Ji, IH; Kim, GE; Kim, HN; Sohn, J; Kim, S and Kim, CW (2001). Purification of soluble beta-glucan with immune-enhancing activity from the cell wall of yeast. Biosci. Biotechnol. Biochem., 65: 837-841.
Lejeune, FJ; Vercammen-Grandjean, A; Mendes da costa, P; Bron, D and Defleur, V (1979). Suppressor cell induction and reticuloendothelial cells activation produced in the mouse by beta-glucan. Adv. Exp. Med. Biol., 121: 235-244.
Lipke, PN and Ovalle, R (1998). Cell wall architecture in yeast: New structure and new challenges. J. Bacteriol., 15: 3735-3740.
Magnelli, P; Cipollo, JF and Abeijon, C (2001). A refined method for the determination of Saccharomyces cerevisiae cell wall composition and beta-(1,6)-glucan fine structure. Analyt. Biochem., 301: 136-150.
Mucksova, J; Babicek, K and Pospisil, M (2001). Particulate beta-(1,3)-D-glucan, carboxymethyl glucan and sulfoethyl glucan-influence of their oral or intraperitoneal administration on immunological respondance of mice. Folia Microbiol., 46: 559-563.
Ohno, N; Egawa, Y; Hashimoto, T; Adachi, Y and Yadomae, T (1996). Effect of beta-glucan on the nitric oxide synthesis by peritoneal macrophage in mice. Biol. Pharm. Bull., 19: 608-612.
Olson, EJ; Standing, JE; Harper, NG; Hoffman, OA and Limper, AH (1996). Fungal beta-glucan interacts with vitronectin and stimulates tumor necrosis factor alpha release from macrophage. Am. Soc. Microbiol., 64: 3548-3554.
Ozinsky, A; Underhill, DM; Fontenot, JD; Hajjar, AM; Smith, KD and Wilson, CB (2000). The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc. Natl. Acad. Sci,, 97: 13766-13771.
Paulsen, BS (2001). Plant polysaccharides with immunostimulatory activities. Curr. Organic Chem., 5: 939-950.
Pillemer, L and Ecker, EE (1941). Anticomplementary factor in fresh yeast. J. Biol. Chem., 137: 1139-1142.
Rice, PJ; Lockhart, BE; Barker, LA; Adams, EL; Ensley, HE and Williams, DL (2004). Pharmacokinetics of fungal beta-(1,3)-D-glucan following intravenous administration in rats. Intl. Immunopharmacol., 4: 1209-1215.
Sell, S (1987). Immunology, Immunopathology and Immunity. 4th edn. Elsevier, USA. 27: 657-664.
Shokri, H (2018). Natural compounds as novel antifungal agents. Amol University of Special Modern Technologies Press.
Steele, W (1991). Clinical application of chemiluminescence of granulocytes Russell. RID. PP: 917-927.
Vetvicka, V; Terayama, K; Mandeville, R; Brousseau, P; Kournikakis, B and Ostroff, G (2002). Orallyadministered yeast beta-(1,3)-glucan prophylactically protects against anthrax infection and cancer in mice. J. Am. Nutr. Assoc., 5: 1-5.
Willaim, DL; Sherwood, ER; Browder, IW and McNamee, RB (1988). Effect of glucan on neutrophil dynamics and immune function in Escherichia coli peritonitis. J. Surg. Res., 44: 54-61.
Xia. Y; Vetvicka, V; Yan, J; Hanikyrova, M; Mayadas, T and Ross, GD (1999). The beta-glucan-binding lectin site of mouse CR3 and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3bopsonized target cells. J. Immunol., 162: 2281-2290.